Development and Manufacture of HI-6 Powder for Solution

Development and manufacture of HI-6 DMS powder for solution product. The Authority requires a supplier to provide services for the development, scale-up, clinical and potential future commercial supply. The supplier will be providing product into UK, Canadian and European Union regulatory areas as a minimum. The supplier will provide all supporting manufacturing studies necessary for all stages of product development. The product should be considered light sensitive for the purposes of long term storage but specific measures should not be necessary for production processes. The Authority will provide the Active Pharmaceutical to the supplier for all activities.